SCHEMBL30958445

SCHEMBL30958445

Cn1cc(C2=C(c3cn(C4CCN(CC(F)(F)F)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCG P05129 11/20 0.78
PRKCB P05771 11/20 0.78
PRKCA P17252 11/20 0.78
PRKCE Q02156 11/20 0.78
PRKCH P24723 10/20 0.78
PRKCD Q05655 10/20 0.78
CAMK2D Q13557 10/20 0.78
CAMK2B Q13554 8/20 0.78
CAMK2G Q13555 8/20 0.78
CAMK2A Q9UQM7 8/20 0.78
PRKCZ Q05513 7/20 0.78
SRC P12931 3/20 0.78
CDK2 P24941 2/20 0.68
GSK3B P49841 2/20 0.68
PIP5K1C O60331 1/20 0.68
RPS6KA5 O75582 1/20 0.68
RPS6KA4 O75676 1/20 0.68
STK16 O75716 1/20 0.68
PAK3 O75914 1/20 0.68
CDK14 O94921 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3155531 1.00 PRKCG (0.78) PRKCGPRKCBPRKCAPRKCEPRKCH
SCHEMBL3149488 0.91 PRKCG (0.73) PRKCGPRKCBPRKCAPRKCEPRKCH
SCHEMBL3158797 0.88 PRKCA (1.00) PRKCGPRKCBPRKCAPRKCEPRKCH
SCHEMBL6423238 0.86 PRKCG (1.00) PRKCGPRKCBPRKCAPRKCEPRKCH
SCHEMBL3146547 0.85 PRKCB (1.00) PRKCGPRKCBPRKCAPRKCEPRKCH
Hydrochloric Acid SCHEMBL3155547 0.84 PRKCB (0.98) PRKCGPRKCBPRKCAPRKCEPRKCH
SCHEMBL1993777 0.82 CAMK2D (0.55) PRKCGPRKCBPRKCAPRKCEPRKCH
SCHEMBL6422277 0.82 PRKCA (1.00) PRKCGPRKCBPRKCAPRKCEPRKCH
SCHEMBL6421778 0.82 PRKCA (1.00) PRKCGPRKCBPRKCAPRKCEPRKCH
SCHEMBL1996178 0.81 CAMK2D (0.56) PRKCGPRKCBPRKCAPRKCEPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4654966-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF OBESITY AND DISEASES ASSOCIATED WITH FAT CELL ENLARGEMENT MELLICELL, INC. (US) 2025-12-03 EP disclosed
WO-2024159211-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF OBESITY AND DISEASES ASSOCIATED WITH FAT CELL ENLARGEMENT MELLICELL, INC. (US) 2024-08-02 WO disclosed